CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy.
Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
T记忆干细胞(T SCM)表现出增强的自我更新和延长存活能力,从而防止T细胞耗竭并促进有效的抗肿瘤T细胞反应。T SCM细胞可通过尿石素A(UA)扩增,UA由共生肠道微生物群从富含鞣花酸的食物中产生,并已知可改善线粒体健康。对荷瘤小鼠口服UA可赋予强烈的抗肿瘤CD8+ T细胞免疫,而体外UA预处理的T细胞在过继性细胞转移后表现出改善的抗肿瘤功能。UA诱导的T SCM形成依赖于Pink1介导的线粒体自噬触发线粒体磷酸酶Pgam5的胞质释放。胞质Pgam5使β-catenin去磷酸化,从而驱动Wnt信号传导和代偿性线粒体生物发生。总之,我们揭示了一条将线粒体自噬与T SCM形成联系起来的关键信号通路,并表明耐受性良好的代谢化合物UA代表了一种改善免疫治疗的有吸引力的选择。
T memory stem cells (T SCM ) display increased self-renewal and prolonged survival capabilities, thus preventing T cell exhaustion and promoting effective anti-tumor T cell responses. T SCM cells can be expanded by Urolithin A (UA), which is produced by the commensal gut microbiome from foods rich in ellagitannins and is known to improve mitochondrial health. Oral UA administration to tumor-bearing mice conferred strong anti-tumor CD8 + T cell immunity, whereas ex vivo UA pre-treated T cells displayed improved anti-tumor function upon adoptive cell transfer.
UA-induced T SCM formation depended on Pink1-mediated mitophagy triggering cytosolic release of the mitochondrial phosphatase Pgam5. Cytosolic Pgam5 dephosphorylated β-catenin, which drove Wnt signaling and compensatory mitochondrial biogenesis. Collectively, we unravel a critical signaling pathway linking mitophagy to T SCM formation and suggest that the well-tolerated metabolic compound UA represents an attractive option to improve immune therapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。